Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Colorado Marijuana Users Health Cohort

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02735954
Recruitment Status : Unknown
Verified October 2018 by National Jewish Health.
Recruitment status was:  Active, not recruiting
First Posted : April 13, 2016
Last Update Posted : March 13, 2019
Sponsor:
Collaborator:
Colorado Department of Public Health and Environment
Information provided by (Responsible Party):
National Jewish Health

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
In Colorado, marijuana is currently used for both recreational and medicinal purposes.To learn more about the positive and negative long term medical effects of marijuana use. Information obtained during this study may identify new markers that influence the development of lung diseases such as COPD. The Investigators are also interested in learning more about the effects of marijuana use for insomnia and how it may or may not affect sleep.

Condition or disease Intervention/treatment
COPD Insomnia Cannabis Other: Marijuana

Detailed Description:

In Colorado, marijuana is currently used for both recreational and medicinal purposes. The major active drug is tetrahydrocannabinol (THC). The most common route of use is through inhalation of the combustion products of the dried, buds/flowers from the female plant either rolled in paper (joint) or burned through a screen in a dry or water filled pipe (bong). Increasingly THC is consumed.

The side effects of the inhalation of burned leaves are controversial. The purpose of this proposal is to establish a prospective cohort of heavy marijuana users to evaluate positive and negative long term medical effects of marijuana use. As marijuana has also been reported for use to help treat insomnia, a sub-study will focus on how marijuana is used for sleep disorders and disturbances.

This study will enroll individuals that use marijuana to learn more about long-term health effects. The study involves one visit where participants will complete questionnaires, breathing tests, blood and urine collection. There is a sub-study where eligible participants will also complete an at-home sleep monitoring test. Participants will be contacted multiple times a year for long-term follow-up.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 2000 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Colorado Marijuana Users Health Cohort
Study Start Date : September 2014
Estimated Primary Completion Date : May 2019
Estimated Study Completion Date : December 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Marijuana

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Marijuana Users
Individuals who use marijuana
 Other: Marijuana
This is an observational study looking at the effects of marijuana on health, including lung health and sleep.
Combined Marijuana and Tobacco Users
Individuals who use marijuana and also smoke cigarettes
 Other: Marijuana
This is an observational study looking at the effects of marijuana on health, including lung health and sleep.
Non-Marijuana Users
Individuals who do not use marijuana


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Long term medical effects of marijuana use [ Time Frame: measured at baseline visit ]

Secondary Outcome Measures :
  1. Quality of sleep [ Time Frame: measured at baseline visit ]
    physiological parameter and questionnaires


Biospecimen Retention:   Samples With DNA
Blood and urine will be collected and retained for study purposes to look at biomarkers and correlated cannabinoid (THC) levels.

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
The Colorado investigators are recruiting 1,000 marijuana only users, 1,000 marijuana and tobacco users, and up to 250 non-marijuana users. The sleep sub-study will include up to 218 eligible participants.
Criteria

Inclusion Criteria:

  • Colorado-only study
  • Age 21-80 years and one of the categories below
  • Marijuana use: use of any cannabis (smoked, vaped, edible, etc.) on average more than 3 days per week for at least 1 year
  • Combined marijuana use and Tobacco use (current or former): ≥ 30 pack year cigarette smoking history
  • Non-marijuana users

Sleep sub-study:

Enrollment in the main cohort building study and a qualifying score on the Insomnia Severity Index questionnaire

Exclusion Criteria:

  • Respiratory disorder other than COPD or asthma
  • Lung surgery with removal of a lobe or more or lung volume reduction surgery
  • Lung cancer or other cancer under active treatment during past 12 months
  • ≥ 30 pack year cigarette smoking history for combined marijuana and cigarette users
  • Pregnancy
  • Use of antibiotics and/or systemic steroids for any lung infection within the last month
  • Inability to use albuterol
  • Subject enrolled in COPDGene or SPIROMICS

Sleep sub-study:

  • Inability to complete home sleep study
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02735954


Locations
Layout table for location information
United States, Colorado
National Jewish Health
Denver, Colorado, United States, 80206
Sponsors and Collaborators
National Jewish Health
Colorado Department of Public Health and Environment
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: National Jewish Health
ClinicalTrials.gov Identifier: NCT02735954    
Other Study ID Numbers: HS 2854
First Posted: April 13, 2016    Key Record Dates
Last Update Posted: March 13, 2019
Last Verified: October 2018
Additional relevant MeSH terms:
Layout table for MeSH terms
Marijuana Abuse
Mental Disorders
Substance-Related Disorders
Chemically-Induced Disorders